Literature DB >> 10934109

Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways.

M Ichinose1, H Sugiura, S Yamagata, A Koarai, K Shirato.   

Abstract

Peroxynitrite, nitrogen dioxide, and other reactive nitrogen species (RNS) that are formed in the reaction of nitric oxide (NO) with superoxide anion, and in peroxidase-dependent mechanisms, have a potent inflammatory action. These molecules may therefore increase in number and have a role in inflammatory airway diseases. In the present study, we quantified RNS using immunostaining of nitrotyrosine and inducible NO synthase (iNOS) in airway inflammatory cells obtained by the induced sputum technique, and also quantified the exhaled NO concentration in subjects with chronic obstructive pulmonary disease (COPD), subjects with asthma, and healthy subjects (HS). Immunoreactivity for iNOS observed in the airway inflammatory cells was significantly and similarly higher in subjects with COPD and asthma than in HS, although exhaled NO levels were increased only in subjects with asthma. Inflammatory cells showed obvious nitrotyrosine immunoreactivity in subjects with COPD and to a lesser extent in those with asthma, but not in HS. There was a significant negative correlation between the percent predicted values of FEV(1) and the amount of nitrotyrosine formation in subjects with COPD, but not in those with asthma and HS. These results suggest that: (1) RNS may be involved in the pathobiology of the airway inflammatory and obstructive process in COPD; and (2) NO produced in the airways, presumably via iNOS, is consumed by its reaction with superoxide anion and/or peroxidase-dependent mechanisms.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10934109     DOI: 10.1164/ajrccm.162.2.9908132

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  81 in total

Review 1.  Oxidative stress in the pathogenesis of asthma.

Authors:  Russell P Bowler
Journal:  Curr Allergy Asthma Rep       Date:  2004-03       Impact factor: 4.806

2.  Cured meat consumption, lung function, and chronic obstructive pulmonary disease among United States adults.

Authors:  Rui Jiang; David C Paik; John L Hankinson; R Graham Barr
Journal:  Am J Respir Crit Care Med       Date:  2007-01-25       Impact factor: 21.405

3.  Theophylline for COPD.

Authors:  P J Barnes
Journal:  Thorax       Date:  2006-09       Impact factor: 9.139

4.  Nitrite in exhaled breath condensate as a marker of nitrossative stress in the airways of patients with asthma, COPD, and idiopathic pulmonary fibrosis.

Authors:  Vladimír Rihák; Petr Zatloukal; Jirina Chládková; Alena Zimulová; Zuzana Havlínová; Jaroslav Chládek
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

Review 5.  The pharmokinetic limitations of antioxidant treatment for COPD.

Authors:  Robert Foronjy; Alison Wallace; Jeanine D'Armiento
Journal:  Pulm Pharmacol Ther       Date:  2007-10-23       Impact factor: 3.410

Review 6.  Chronic obstructive pulmonary disease * 12: New treatments for COPD.

Authors:  P J Barnes
Journal:  Thorax       Date:  2003-09       Impact factor: 9.139

7.  The Effect of Cigarette Smoke-derived Oxidants on the Inflammatory Response of the Lung.

Authors:  Robert Foronjy; Jeanine D'Armiento
Journal:  Clin Appl Immunol Rev       Date:  2006-01-01

Review 8.  Molecular mechanisms of nitrogen dioxide induced epithelial injury in the lung.

Authors:  Rebecca L Persinger; Matthew E Poynter; Karna Ckless; Yvonne M W Janssen-Heininger
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

9.  The influence of free 3-nitrotyrosine and saliva on the quantitative analysis of protein-bound 3-nitrotyrosine in sputum.

Authors:  Kazuhito Ueshima; Yoshiaki Minakata; Hisatoshi Sugiura; Satoru Yanagisawa; Tomohiro Ichikawa; Keiichirou Akamatsu; Tsunahiko Hirano; Masanori Nakanishi; Kazuto Matsunaga; Toshiyuki Yamagata; Masakazu Ichinose
Journal:  Anal Chem Insights       Date:  2007-02-14

10.  Exhaled nitric oxide in stable chronic obstructive pulmonary disease.

Authors:  Mohammed F S Beg; Mohammad A Alzoghaibi; Abdullah A Abba; Syed S Habib
Journal:  Ann Thorac Med       Date:  2009-04       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.